MENU
+Compare
INCR
Stock ticker: NASDAQ
AS OF
Apr 24, 10:55 AM (EDT)
Price
$1.46
Change
-$0.00 (-0.00%)
Capitalization
123.5M

INCR Intercure Ltd Forecast, Technical & Fundamental Analysis

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products... Show more

INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for INCR with price predictions
Apr 23, 2025

INCR's RSI Oscillator recovers from oversold territory

The RSI Indicator for INCR moved out of oversold territory on April 14, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In of the 30 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on INCR as a result. In of 117 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for INCR just turned positive on April 16, 2025. Looking at past instances where INCR's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INCR advanced for three days, in of 203 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

INCR broke above its upper Bollinger Band on April 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for INCR entered a downward trend on April 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.928) is normal, around the industry mean (61.171). P/E Ratio (22.519) is within average values for comparable stocks, (90.174). INCR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (1.145) is also within normal values, averaging (20.123).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. INCR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

INCR is expected to report earnings to fall 29.33% to 2 cents per share on May 19

Intercure Ltd INCR Stock Earnings Reports
Q1'25
Est.
$0.02
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.02
Q2'24
Est.
$-0.01
Q1'24
Beat
by $0.08
The last earnings report on April 07 showed earnings per share of 2 cents, beating the estimate of 0 cents. With 602.00 shares outstanding, the current market capitalization sits at 123.50M.
A.I. Advisor
published General Information

General Information

a provider of outsourced clinical development and commercialization services to biopharmaceutical companies

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
85 Medinat ha-Yehudim Street
Phone
+972 774605012
Employees
370
Web
https://www.intercure.co
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EUGAX25.23N/A
N/A
Morgan Stanley Europe Opportunity A
PARWX47.61N/A
N/A
Parnassus Value Equity Investor
ABVCX16.15N/A
N/A
AB Large Cap Value C
CFIGX13.09N/A
N/A
Columbia Flexible Capital Income C
LSEIX14.22N/A
N/A
Persimmon Long/Short I

INCR and Stocks

Correlation & Price change

A.I.dvisor tells us that INCR and TLRY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INCR and TLRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCR
1D Price
Change %
INCR100%
+5.80%
TLRY - INCR
29%
Poorly correlated
-3.84%
KMDA - INCR
26%
Poorly correlated
+1.70%
SNDL - INCR
25%
Poorly correlated
+1.79%
ACB - INCR
24%
Poorly correlated
+3.29%
OGI - INCR
24%
Poorly correlated
+1.89%
More